Clinical Trials | April 08, 2026
Amgen’s TEPEZZA injection clears Phase 3 trial with high efficacy
The trial also demonstrated significant improvements across multiple secondary endpoints
The trial also demonstrated significant improvements across multiple secondary endpoints
New adult supplement combines 26 vitamins, minerals and botanicals to address stress, energy, immunity and cognitive wellness in one daily tablet
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
Subscribe To Our Newsletter & Stay Updated
